ArticleMikrochimica acta2026
Harnessing MOF on MOF composite for high ratiometric fluorescent tetracycline detection.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Tetracycline (TC) compounds, which Metal-organic frameworks (MOFs), a class of porous crystalline materials with designable structures and fluorescence properties, have become ideal candidate materials for constructing ratiometric fluorescent sensors. To enable rapid and convenient detection of tetracycline (TC), we developed a novel CAU-1-on-EuMOF heterostructure, in which EuMOF nanoparticles grow on the surface of blue-emitting CAU-1. This unique architecture achieves efficient dual-emission ratiometric sensing through the synergistic effect of the antenna effect and the inner filter effect, significantly improving selectivity and self-calibration capability. The ratiometric fluorescence sensing platform constructed from this composite material exhibits a limit of detection (LOD) for tetracycline as low as 200 nM. The platform also demonstrated excellent selectivity for TC over other substances. The sensing platform was further tested on real samples, including tap water, milk, and fish. In these tests, the recoveries ranged from 93.53% to 112.07%. These findings highlight the substantial potential of the MOF-on-MOF hybrid material for advanced sensing applications.
Indexed as
Identifiers
42423849What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.